News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,726 Results
Type
Article (32352)
Company Profile (12)
Press Release (143362)
Section
Business (53975)
Career Advice (374)
Deals (3689)
Drug Delivery (7)
Drug Development (24543)
Employer Resources (34)
FDA (3526)
Job Trends (3364)
News (83767)
Policy (4543)
Tag
Academia (2402)
Alliances (11303)
ALS (21)
Alzheimer's disease (484)
Approvals (3528)
Artificial intelligence (36)
Best Places to Work (2834)
Breast cancer (60)
Cancer (419)
Cardiovascular disease (30)
Career advice (342)
CAR-T (29)
Cell therapy (78)
Clinical research (18793)
Collaboration (108)
COVID-19 (1202)
C-suite (76)
Data (499)
Diabetes (36)
Diagnostics (1656)
Earnings (6770)
Employer resources (31)
Events (18382)
Executive appointments (254)
FDA (3664)
Funding (119)
Gene therapy (50)
GLP-1 (139)
Government (974)
Healthcare (5209)
Infectious disease (1221)
Inflammatory bowel disease (33)
Interviews (43)
IPO (1604)
Job creations (607)
Job search strategy (320)
Layoffs (39)
Legal (786)
Lung cancer (49)
Lymphoma (31)
Manufacturing (26)
Medical device (3141)
Medtech (3142)
Mergers & acquisitions (2117)
Metabolic disorders (91)
Neuroscience (556)
NextGen Class of 2024 (1879)
Non-profit (1770)
Northern California (445)
Obesity (38)
Opinion (31)
People (32456)
Phase I (5941)
Phase II (8579)
Phase III (5788)
Pipeline (96)
Postmarket research (980)
Preclinical (3083)
Press Release (25)
Radiopharmaceuticals (66)
Rare diseases (62)
Real estate (1339)
Regulatory (3110)
Research institute (1367)
Resumes & cover letters (24)
Southern California (338)
Startups (1176)
United States (3421)
Vaccines (186)
Weight loss (22)
Date
Today (5)
Last 7 days (23)
Last 30 days (513)
Last 365 days (7831)
2024 (7831)
2023 (9648)
2022 (11866)
2021 (13671)
2020 (13310)
2019 (12757)
2018 (9501)
2017 (9076)
2016 (9285)
2015 (10637)
2014 (8051)
2013 (7783)
2012 (7765)
2011 (7758)
2010 (6951)
Location
Africa (271)
Arizona (35)
Asia (10488)
Australia (2646)
California (896)
Canada (336)
China (69)
Colorado (44)
Connecticut (48)
Europe (28186)
Florida (108)
Georgia (36)
Illinois (106)
Indiana (48)
Japan (25)
Maryland (102)
Massachusetts (584)
Michigan (36)
Minnesota (49)
New Jersey (239)
New York (276)
North Carolina (216)
Northern California (445)
Ohio (52)
Pennsylvania (183)
South America (297)
Southern California (338)
Texas (136)
Utah (28)
Washington State (98)
175,726 Results for "george mason university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Theralink Technologies is excited to announce groundbreaking work by George Mason University and the University of California, San Francisco, recently published in Cell Reports Medicine.
December 18, 2023
·
8 min read
Drug Development
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
HCW Biologics Inc. will have a human data readout at the 38th Annual Meeting of the Society for Immunotherapy of Cancer from an ongoing Phase 1 clinical trial to evaluate HCW9218 in patients with chemo-refractory/chemo-resistant solid tumors, conducted by the Masonic Cancer Center, University of Minnesota.
November 1, 2023
·
5 min read
Business
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
Calidi Biotherapeutics, Inc. today announced the appointment of Dr. George E. Peoples, MD, FACS, to the company’s Board of Directors, effective July 1, 2024.
June 27, 2024
·
4 min read
Business
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
George Medicines announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately.
April 29, 2024
·
3 min read
Business
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies announced that translational immunology expert George Vratsanos, M.D., FACR, is joining its board of directors.
June 13, 2024
·
5 min read
Press Releases
Potential of George Medicines’ novel, low-dose, triple combination pill to transform management of hypertension highlighted at global congress
September 25, 2024
·
6 min read
Business
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and Chief Executive Officer
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the company as President and Chief Executive Officer (CEO).
March 28, 2024
·
2 min read
Business
Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19
Tetra, Targeted Pharmaceutical and the George Mason University National Center for Biodefense and Infectious Diseases (NCBID) sign a research collaboration
October 22, 2020
·
7 min read
Business
Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies
Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies
April 22, 2020
·
6 min read
Business
Citius Pharmaceuticals Announces Addition of City of Hope to UMN’s Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Citius Pharmaceuticals, Inc. today announced that the University of Minnesota Masonic Cancer Center intends to expand their ongoing investigator-initiated Phase 1 trial of LYMPHIR™ (denileukin diftitox) in combination with FDA-approved CAR-T products for the treatment of B-cell lymphomas.
April 11, 2024
·
7 min read
1 of 17,573
Next
